| Interleukin-1β immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures A Vezzani, M Conti, A De Luigi, T Ravizza, D Moneta, F Marchesi, ... Journal of Neuroscience 19 (12), 5054-5065, 1999 | 733 | 1999 |
| Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study F Passamonti, C Cattaneo, L Arcaini, R Bruna, M Cavo, F Merli, ... The Lancet Haematology 7 (10), e737-e745, 2020 | 546 | 2020 |
| Triazene compounds: mechanism of action and related DNA repair systems F Marchesi, M Turriziani, G Tortorelli, G Avvisati, F Torino, L De Vecchis Pharmacological research 56 (4), 275-287, 2007 | 376 | 2007 |
| UBQLN2 mediates autophagy-independent protein aggregate clearance by the proteasome R Hjerpe, JS Bett, MJ Keuss, A Solovyova, TG McWilliams, C Johnson, ... Cell 166 (4), 935-949, 2016 | 293 | 2016 |
| COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) L Pagano, J Salmanton-García, F Marchesi, A Busca, P Corradini, ... Journal of hematology & oncology 14 (1), 168, 2021 | 252 | 2021 |
| Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary … F Pimpinelli, F Marchesi, G Piaggio, D Giannarelli, E Papa, P Falcucci, ... Journal of hematology & oncology 14, 1-12, 2021 | 180 | 2021 |
| Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy C Girmenia, GM Rossolini, A Piciocchi, A Bertaina, G Pisapia, D Pastore, ... Bone marrow transplantation 50 (2), 282-288, 2015 | 170 | 2015 |
| Incidence, risk factors and outcome of pre-engraftment gram-negative bacteremia after allogeneic and autologous hematopoietic stem cell transplantation: an Italian prospective … C Girmenia, A Bertaina, A Piciocchi, K Perruccio, A Algarotti, A Busca, ... Clinical Infectious Diseases 65 (11), 1884-1896, 2017 | 137 | 2017 |
| Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations L Pagano, A Busca, A Candoni, C Cattaneo, S Cesaro, R Fanci, G Nadali, ... Blood reviews 31 (2), 17-29, 2017 | 114 | 2017 |
| Busca L Pagano, J Salmanton-García, F Marchesi A, 2013 | 114 | 2013 |
| Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on … S Cesaro, P Ljungman, M Mikulska, HH Hirsch, M von Lilienfeld-Toal, ... Leukemia 36 (6), 1467-1480, 2022 | 105 | 2022 |
| High density of CD68+/CD163+ tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in … F Marchesi, M Cirillo, A Bianchi, M Gately, OM Olimpieri, E Cerchiara, ... Hematological oncology 33 (2), 110-112, 2015 | 102 | 2015 |
| Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria C Cattaneo, R Di Blasi, C Skert, A Candoni, B Martino, N Di Renzo, ... Annals of hematology 97, 1717-1726, 2018 | 95 | 2018 |
| COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA L Pagano, J Salmanton-García, F Marchesi, A López-García, S Lamure, ... Blood, The Journal of the American Society of Hematology 139 (10), 1588-1592, 2022 | 82 | 2022 |
| CXCL13 expression in the gut promotes accumulation of IL-22-producing lymphoid tissue-inducer cells, and formation of isolated lymphoid follicles F Marchesi, AP Martin, N Thirunarayanan, E Devany, L Mayer, ... Mucosal immunology 2 (6), 486-494, 2009 | 77 | 2009 |
| Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey L Pagano, J Salmanton-García, F Marchesi, O Blennow, ... Blood, The Journal of the American Society of Hematology 140 (26), 2773-2787, 2022 | 63 | 2022 |
| Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant F Marchesi, F Pimpinelli, F Ensoli, A Mengarelli Hematological oncology 36 (2), 381-391, 2018 | 62 | 2018 |
| COVID‐19 elicits an impaired antibody response against SARS‐CoV‐2 in patients with haematological malignancies F Passamonti, A Romano, M Salvini, F Merli, MGD Porta, R Bruna, ... British Journal of Haematology 195 (3), 371-377, 2021 | 60 | 2021 |
| Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: an EPICOVIDEHA survey report O Blennow, J Salmanton‐García, P Nowak, F Itri, J Van Doesum, ... American journal of hematology 97 (8), E312-E317, 2022 | 49 | 2022 |
| COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP A Busca, J Salmanton-García, P Corradini, F Marchesi, A Cabirta, ... Blood Advances 6 (7), 2427-2433, 2022 | 46 | 2022 |
